The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease

The Combination of Ophthalmologic Tests and EEG Imaging as a New Biomarker for Alzheimer's Disease

Alzheimer's disease (AD) is a prevalent, long-term progressive degenerative disorder with great social impact. It is currently thought that, in addition to neurodegeneration, vascular changes also play a role in the pathophysiology of the disease. Meantime, EEG resting state has also demonstrated significant change in patients with AD in neuroscience research area. Thus, the combination of these sensitive biomarkers would lead to a potential new biomarker for detection of AD, which has higher specificity and sensitivity.

The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease

Recruitment

Summary

Participation Requirements

Description

Tracking Information